Literature DB >> 5760587

Some clinical potentials of chlorophenoxyisobutyrate (Clofibrate) therapy. (Hyperlipidemia--angina pectoris--blood sludging--diabetic neuropathy).

G G Duncan, F A Elliott, T G Duncan, J Schatanoff.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5760587      PMCID: PMC2441170     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN: 0065-7778


× No keyword cloud information.
  7 in total

1.  THE SEPARATE HYPOLIPOPROTEINEMIC EFFECTS OF DEXTROTHYROXINE AND ETHYL CHLOROPHENOXYISOBUTYRATE.

Authors:  E H STRISOWER; B STRISOWER
Journal:  J Clin Endocrinol Metab       Date:  1964-02       Impact factor: 5.958

2.  THE EFFECTS OF ATROMID ON THE METABOLISM OF ADRENAL STEROIDS AND ON PLASMA LIPID FRACTIONS.

Authors:  C BERRY; A MOXHAM; E SMITH; A E KELLIE; J D NABARRO
Journal:  J Atheroscler Res       Date:  1963 Sep-Dec

3.  A STUDY OF THE EFFECT OF ATROMID THERAPY IN EXUDATIVE DIABETIC RETINOPATHY.

Authors:  J T IRELAND; J F CULLEN; M F OLIVER; L J DUNCAN
Journal:  J Atheroscler Res       Date:  1963 Sep-Dec

4.  REDUCTION OF CHOLESTEROL AND LIPIDS IN MAN BY ETHYL P-CHLOROPHENOXYISOBUTYRATE.

Authors:  L HELLMAN; B ZUMOFF; G KESSLER; E KARA; I L RUBIN; R S ROSENFELD
Journal:  Ann Intern Med       Date:  1963-10       Impact factor: 25.391

5.  Hypolipidemic effect of chlorophenoxyisobutyrate in adult-onset diabetes mellitus.

Authors:  T S Danowski; J F Novak; R W Saul; J W Vester; C Moses
Journal:  Clin Pharmacol Ther       Date:  1966 Sep-Oct       Impact factor: 6.875

6.  Effect of atromid and ethyl chlorophenoxyisobutyrate on anticoagulant requirements.

Authors:  M F OLIVER; S D ROBERTS; D HAYES; J F PANTRIDGE; M M SUZMAN; I BERSOHN
Journal:  Lancet       Date:  1963-01-19       Impact factor: 79.321

7.  Settling of sludge in human patients; a contribution to be biophysics of disease.

Authors:  F HARDING; M H KNISELY
Journal:  Angiology       Date:  1958-12       Impact factor: 3.619

  7 in total
  2 in total

1.  Lipid-lowering therapy and peripheral sensory neuropathy in type 2 diabetes: the Fremantle Diabetes Study.

Authors:  T M E Davis; B B Yeap; W A Davis; D G Bruce
Journal:  Diabetologia       Date:  2008-01-11       Impact factor: 10.122

Review 2.  Non-glucose risk factors in the pathogenesis of diabetic peripheral neuropathy.

Authors:  Kyung Ae Lee; Tae Sun Park; Heung Yong Jin
Journal:  Endocrine       Date:  2020-09-07       Impact factor: 3.633

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.